dgn-np:NP49734.RAVgWk0TZj5wExrEoXX6bF-jpWQFp6pk0PozGrD-nzViU130_provenance {
dgn-np:NP49734.RAVgWk0TZj5wExrEoXX6bF-jpWQFp6pk0PozGrD-nzViU130_assertion dcterms:description "[Po-husk, apart from lowering LDL-C, also reduced TG, TG related to certain gene variants, TC, Apo B-100, oxLDL, insulin-resistance and systolic BP in mild-moderate hypercholesterolaemic individuals. Thus, the target patients to receive Po-husk would be those who present a cluster of various CVD risk factors, such as metabolic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ;
wi:evidence dgn-void:source_evidence_literature ;
sio:SIO_000772 miriam-pubmed:20413122 ;
prov:wasDerivedFrom dgn-void:gad-20130706 ;
prov:wasGeneratedBy eco:ECO_0000203 .
dgn-void:gad-20130706 pav:importedOn "2013-07-06"^^
xsd:date .
dgn-void:source_evidence_literature a eco:ECO_0000212 ;
rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en ;
rdfs:label "DisGeNET evidence - LITERATURE"@en .
}